Dividend Declaration (7252P)
October 06 2011 - 10:26AM
UK Regulatory
TIDMHIK
RNS Number : 7252P
Hikma Pharmaceuticals Plc
06 October 2011
Hikma Pharmaceuticals PLC
Interim Dividend for 2011
LONDON, 6 October 2011 - Hikma Pharmaceuticals PLC ("the
Company") advises that, as previously announced with the interim
results, the interim dividend of 5.5 cents per will be paid on 13
October 2011 to shareholders on the register on 9 September
2011.
Shareholders who have elected to receive their dividend in
Pounds Sterling will receive 3.555 pence per Ordinary Share
(exchange rate US$1.5470 to GBPGBP1).
Shareholders who have elected to receive their dividend in
Jordanian Dinar will receive 7.768 qirsh (piastres) per Ordinary
Share (exchange rate US$0.708 to JOD1).
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
Henry Knowles
Company Secretary +44 20 7399 2670
Susan Ringdal
Investor Relations Director +44 20 7399 2670
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed pharmaceutical
products. Hikma's operations are conducted through three
businesses: "Branded", "Injectables" and "Generics". Hikma's
operations are based principally in the Middle East and North
Africa ("MENA") region, where it is a market leader and sells
across 17 countries, the United States and Europe. In 2010, the
Group achieved revenues of $731 million (2009 $637 million) and
profit attributable to shareholders was $99 million (2009 $78
million).
This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVMFBITMBTMBAB
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024